Total Clarity Wealth Management, Inc. Novavax Inc Transaction History

Total Clarity Wealth Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$36.28 - $75.29 $1,814 - $3,764	50 New	50 $3,000
Q1 2022 Apr 29, 2022	SELL	$69.73 - $142.9 $3,486 - $7,145	-50 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$177.8 - $270.58 $8,890 - $13,529	50 New	50 $10,000
Q2 2021 Jul 26, 2021	SELL	$121.0 - $257.67 $5,566 - $11,852	-46 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$112.98 - $319.93 $5,197 - $14,716	46 New	46 $8,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.